Scarica l'app Stockscreener
10.12
1.36%
-0.14
Dopo l'orario di chiusura:
10.14
0.02
+0.20%
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Niagen: Imminent Trigger For A Significant Move Up (Technical Analysis) - Seeking Alpha
Niagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC Wainwright - MarketBeat
Q2 EPS Forecast for Niagen Bioscience Increased by Analyst - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Average PT from Brokerages - MarketBeat
Niagen Bioscience stock price target raised to $12 from $11 at H.C. Wainwright - Investing.com Canada
Real time scanner hits for Niagen Bioscience Inc. explainedRisk Balanced Picks for Safer Trading - Newser
Niagen Bioscience Reports Strong Q2 Growth and Outlook - TipRanks
Is Niagen Bioscience Inc. a defensive stockFree Investment Webinars - classian.co.kr
News impact scoring models applied to Niagen Bioscience Inc.In-Depth Stock Trading Volume Analysis - Newser
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Earnings Beat - MarketBeat
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Roth Capital Cuts Earnings Estimates for Niagen Bioscience - MarketBeat
Risk adjusted return profile for Niagen Bioscience Inc. analyzedSafe and Scalable Return Strategy Blueprint - Newser
Can Niagen Bioscience Inc. rally from current levelsLow Risk Strategy with Smart Entry Zones - Newser
Will a bounce in Niagen Bioscience Inc. offer an exitProven Trading System with Consistent Gains - Newser
Niagen Bioscience, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of “Buy” by Brokerages - Defense World
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Should you wait for a breakout in Niagen Bioscience Inc.Free Fundamental Growth Stock Analysis - Newser
Niagen Bioscience Reports Strong Q2 Sales Growth - The Globe and Mail
Niagen Bioscience: Q2 Earnings Snapshot - New Haven Register
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Niagen Bioscience shares rise 21.91% premarket after Q2 sales beat estimates. - AInvest
Earnings call transcript: Niagen Bioscience Q2 2025 earnings beat expectations - Investing.com
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - BioSpace
Niagen NAGE Q2 2025 Earnings Call Transcript - Mitrade
Niagen Bioscience shares rise 24.88% after-hours after Q2 sales beat estimates. - AInvest
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Transcript : Niagen Bioscience, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% - Investing.com Nigeria
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% By Investing.com - Investing.com South Africa
Niagen Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - 富途牛牛
What You Can Learn From Niagen Bioscience, Inc.'s (NASDAQ:NAGE) P/S After Its 28% Share Price Crash - simplywall.st
Niagen Bioscience shares fall 3.53% premarket ahead of CEO's participation in Canaccord Genuity's 45th Annual Growth Conference. - AInvest
Niagen Bioscience Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference - BioSpace
Niagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street Zen - Defense World
Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference - Lelezard
What is the dividend policy of Niagen Bioscience Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What makes Niagen Bioscience Inc. stock price move sharplyTrend Reversal Watch with Entry Signals - Newser
Should I hold or sell Niagen Bioscience Inc. stock in 2025Get daily expert analysis on top stocks - Jammu Links News
What is Niagen Bioscience Inc. company’s growth strategyGet exclusive access to professional stock picks - Jammu Links News
Is Niagen Bioscience Inc. a growth stock or a value stockFree Predictions - Jammu Links News
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for Niagen Bioscience Inc. in the next 12 monthsHigh-profit stock alerts - Jammu Links News
How strong is Niagen Bioscience Inc. company’s balance sheetDiscover high-impact stocks for your portfolio - Jammu Links News
When is Niagen Bioscience Inc. stock expected to show significant growthUnlock powerful trading alerts for success - Jammu Links News
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):